2005•Journal of Qilu OncologyRequires access

Expression of heat shock proteins 70 in lung cancer

Han Yong

Open publisher page 0 citations

Abstract

OBJECTIVE:To discuss expression of HSP70 in non-small cell lung cancer (NSCLC) tissues and its pathological significance. METHODS: Immunohistochemical study on the expression of HSP70 in NSCLC tissues was performed, and the correlation between the expression of HSP in the NSCLC tissues and cell types, differentiation, as well as clinical stages of NSCLC were investigaled. RESULTS: The expression of HSP70 cases were positive in 37 cases of NSCLC, which was markedly increased compared with the control. In 26 cases of squamous cell carcinoma, the expression of HSP70 cases were positive in 20 cases, while 17 cases were positive in 21 cases of adenocarcinoma. P0.05; In 16 cases of highly differentiaed carcinoma, the expression of HSP70 was positive in 10 cases, while 27 cases were positive in 31 cases of middle and low differential type. (P0.05). Meanwhile, in 20 cases of Stage Ⅰ-Ⅱ carcinoma, the expression of HSP70 was positive in 13 cases, and 24 cases were positive in 27 cases of Stage Ⅲ-Ⅳ. P0.05; In 30 cases of NSCLC with lymph node metastasis,the expression of HSP70 was positive in 27 cases, while 10 cases were positive in 17 cases without lymph node metastasis, P0.05. The expression of HSP70 was markedly increased in tumor tissues, and was also significantly related to the NSCLC clinical staging, but it is not related to the cell types of NSCLC. CONSLUSION: HSP70 might be a usetul marker of the biological behavior in NSCLC.

About this research paper

What this paper is about

OBJECTIVE:To discuss expression of HSP70 in non-small cell lung cancer (NSCLC) tissues and its pathological significance. METHODS: Immunohistochemical study on the expression of HSP70 in NSCLC tissues was performed, and the correlation between the expression of HSP in the NSCLC tissues and cell types, differentiation, as well as clinical stages of NSCLC were investigaled. RESULTS: The expression of HSP70 cases were positive in 37 cases of NSCLC, which was markedly increased compared with the control. In 26 cases of squamous cell carcinoma, the expression of HSP70 cases were positive in 20 cases, while 17 cases were positive in 21 cases of adenocarcinoma. P0.05; In 16 cases of highly differentiaed carcinoma, the expression of HSP70 was positive in 10 cases, while 27 cases were positive in 31 cases of middle and low differential type. (P0.05). Meanwhile, in 20 cases of Stage Ⅰ-Ⅱ carcinoma, the expression of HSP70 was positive in 13 cases, and 24 cases were positive in 27 cases of Stage Ⅲ-Ⅳ. P0.05; In 30 cases of NSCLC with lymph node metastasis,the expression of HSP70 was positive in 27 cases, while 10 cases were positive in 17 cases without lymph node metastasis, P0.05. The expression of HSP70 was markedly increased in tumor tissues, and was also significantly related to the NSCLC clinical staging, but it is not related to the cell types of NSCLC. CONSLUSION: HSP70 might be a usetul marker of the biological behavior in NSCLC.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To discuss expression of HSP70 in non-small cell lung cancer (NSCLC) tissues and its pathological significance. METHODS: Immunohistochemical study on the expression of HSP70 in NSCLC tissues was performed, and the correlation between the expression of HSP in the NSCLC tissues and cell types, differentiation, as well as clinical stages of NSCLC were investigaled. RESULTS: The expression of HSP70 cases were positive in 37 cases of NSCLC, which was markedly increased compared with the control. In 26 cases of squamous cell carcinoma, the expression of HSP70 cases were positive in 20 cases, while 17 cases were positive in 21 cases of adenocarcinoma. P0.05; In 16 cases of highly differentiaed carcinoma, the expression of HSP70 was positive in 10 cases, while 27 cases were positive in 31 cases of middle and low differential type. (P0.05). Meanwhile, in 20 cases of Stage Ⅰ-Ⅱ carcinoma, the expression of HSP70 was positive in 13 cases, and 24 cases were positive in 27 cases of Stage Ⅲ-Ⅳ. P0.05; In 30 cases of NSCLC with lymph node metastasis,the expression of HSP70 was positive in 27 cases, while 10 cases were positive in 17 cases without lymph node metastasis, P0.05. The expression of HSP70 was markedly increased in tumor tissues, and was also significantly related to the NSCLC clinical staging, but it is not related to the cell types of NSCLC. CONSLUSION: HSP70 might be a usetul marker of the biological behavior in NSCLC.

Key concepts: Hsp70, Immunohistochemistry, Medicine, Stage (stratigraphy), Lung cancer, Adenocarcinoma, Pathological, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of heat shock proteins 70 in lung cancer — Research Paper | ScholarLens